FinTrust Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $81.2K | Buy |
419
+12
| +3% | +$2.33K | 0.01% | 469 |
|
|
2024
Q2 | $94.4K | Buy |
407
+83
| +26% | +$19.2K | 0.02% | 409 |
|
|
2024
Q1 | $69.9K | Sell |
324
-55
| -15% | -$11.9K | 0.01% | 445 |
|
|
2023
Q4 | $98.1K | Sell |
379
-68
| -15% | -$17.6K | 0.02% | 370 |
|
|
2023
Q3 | $115K | Buy |
447
+406
| +990% | +$104K | 0.03% | 316 |
|
|
2023
Q2 | $11.4K | Hold |
41
| – | – | ﹤0.01% | 740 |
|
|
2023
Q1 | $11.4K | Hold |
41
| – | – | ﹤0.01% | 739 |
|
|
2022
Q4 | $11.4K | Hold |
41
| – | – | ﹤0.01% | 739 |
|
|
2022
Q3 | $11K | Hold |
41
| – | – | ﹤0.01% | 841 |
|
|
2022
Q2 | $8K | Buy |
41
+28
| +215% | +$5.46K | ﹤0.01% | 935 |
|
|
2022
Q1 | $3K | Hold |
13
| – | – | ﹤0.01% | 1108 |
|
|
2021
Q4 | $3K | Hold |
13
| – | – | ﹤0.01% | 1066 |
|
|
2021
Q3 | $4K | Hold |
13
| – | – | ﹤0.01% | 1030 |
|
|
2021
Q2 | $5K | Hold |
13
| – | – | ﹤0.01% | 1026 |
|
|
2021
Q1 | $4K | Hold |
13
| – | – | ﹤0.01% | 1029 |
|
|
2020
Q4 | $3K | Sell |
13
-133
| -91% | -$30.7K | ﹤0.01% | 978 |
|
|
2020
Q3 | $41 | Sell |
146
-216
| -60% | -$61 | 0.01% | 520 |
|
|
2020
Q2 | $97K | Sell |
362
-258
| -42% | -$69.1K | 0.04% | 338 |
|
|
2020
Q1 | $196K | Buy |
620
+182
| +42% | +$57.5K | 0.09% | 180 |
|
|
2019
Q4 | $130K | Buy |
438
+100
| +30% | +$29.7K | 0.05% | 289 |
|
|
2019
Q3 | $79K | Buy |
338
+91
| +37% | +$21.3K | 0.03% | 350 |
|
|
2019
Q2 | $58K | Sell |
247
-32
| -11% | -$7.51K | 0.02% | 377 |
|
|
2019
Q1 | $66K | Sell |
279
-9
| -3% | -$2.13K | 0.03% | 339 |
|
|
2018
Q4 | $87K | Buy |
+288
| New | +$87K | 0.04% | 281 |
|